Hepatocellular carcinoma: Comparison between gadolinium and iron-oxide enhanced MR imaging;Risonanza magnetica epatica ed epatocarcinoma: Confronto fra risultati ottenuti con mezzo di contrasto paramagnetico (gadolinio) e superparamagnetico (particelle di ossido di ferro)

Radiologia Medica

Volumn 100, Issue 3, 2000, Pages 160-167

  Castoldi, Maria Chiara ^a   Fauda, Valerio ^a   Scaramuzza, Davide ^a   Vergnaghi, Daniele ^a   Fauda, Dott V ^a  

^a SAN CARLO BORROMEO HOSPITAL   (Italy)

Author keywords

Contrast enhancement; HCC HCC; Liver; MRI HCC MRI

Indexed keywords

GADOLINIUM PENTETATE; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; LIVER STRUCTURE; NUCLEAR MAGNETIC RESONANCE IMAGING; RATING SCALE;

AGED; CARCINOMA, HEPATOCELLULAR; FERRIC COMPOUNDS; GADOLINIUM; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOISOTOPES; SENSITIVITY AND SPECIFICITY;

EID: 0033667549     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Arbab AS, Icchikawa T, Araki T e Coll: Detection of hepatocellular carcinoma and its metastases with various pulse sequences using superparamagnetic iron oxide. Abdom Imaging 25: 151-158, 2000.
2. Bach-Gamso T, Fahlvik AK, Ericsson A e Coll: Superparamagnetic iron oxide for liver imaging. Comparison among three different preparations. Invest Radiol 29: 339-344, 1994.
3. Bellin MR, Zaim S, Auberton E e Coll: Liver metastases: safety and efficacity of detection with superparamagnetic iron oxide MR imaging. Radiology 193: 657-663, 1994.
4. Blakeborough A, Ward J, Wilson D e Coll: Hepatic lesion detection at MR imaging: a comparative study with four sequences. Radiology 203: 759-765, 1997.
5. Clement O, Frija G, Chambon C e Coll: Liver tumors in cirrhosis: Experimental study with SPIO-enhaneed MR Imaging. Radiology 180: 31-36, 1991.
6. Colombo M: Hepatocellular carcinoma in cirrhotics. Semin Liv Dis 13: 374-383, 1993.
7. Deckers F, Corthouts B, Nackaerts Y e Coll: Influence of MR field strength on the detection of focal liver lesions with superparamagnetic iron oxide. Eur Radiol 7: 887-891, 1997.
8. Di Cesare E, Cariello G, Marchese F e Coll: Superparamagnetic iron oxide in the differential diagnosis of focal hepatic lesions using a 0.5 Tesla magnetic resonance apparatus. Radiol Med 95: 593-598, 1998.
9. Duda SH, Laniado M, Kopp AF, e Coll: Superparamagnetic iron oxide: detection of focal liver lesions at high-field strength MR imaging. J Magn Reson Imaging 4: 309-314, 1994.
10. Finazzo M, Midiri M, Gallo C e Coll: Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagnetic contrast medium. Radiol Med 95: 599-607, 1998.
11. Fukuya T, Honda H, Maeda T: Well differentiated hepatocellular carcinoma: isointense to liver parenchyma on superparamagnetic iron oxide-enhanced MR. Radiat Med 13: 35-37, 1995.
12. Hagspiel KD, Neidl KF, Eichenberger AC e Coll: Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unhenanced MR Imaging at 1.5 T with dynamic CT, Intra-operative US, and Percutaneous US. Radiology 196: 471-478, 1995.
13. Hollett MD, Jeffrey RBJ, Nino-Murcia M e Coll: Dual phase helical CT of the liver: value of arterial phase scans in the detection of small (1.5 cm) malignant hepatic neoplasms. AJR 164: 879-884, 1995.
14. Ichikawa T, Arbab AS, Araki T e Coll: Perfusion MR imaging with a superparamagnetic iron oxide using T2-weighted and susceptibility-sensitive echoplanar sequences: evaluation of tumor vascularity in hepatocellular carcinoma. AJR 173: 207-213, 1999.
15. Kanematsu M, Hoshi H, Sone Y e Coll: Detection of hepatic tumors: arterial-phase MR imaging versus spiral CT arteriography. Abdom Imag 23: 416-420, 1998.
16. Kew MC, Popper H: Relationship between hepatocellular carcinoma and cirrhosis. Semin Liv Dis 4: 136-140, 1984.
17. Larson RE, Semelka RC, Bagley AS e Coll: Hypervascular malignant liver lesions: comparison of various MR imaging pulse sequences and dynamic CT: Radiology 192: 393-399, 1994.
18. Mazzaferro V, Regalia E, Doci R e Coll: Liver transplantation for the treatement of small hepatocellular carcinomas in patients with cirrhosis. N Engl Med 334: 693-699, 1996.
19. Mergo PJ, Engelken JD, Helmberger T e Coll: MRI in focal liver disease: a comparison of small and ultra small superparamagnetic iron oxide as hepatic contrast agents. J Magn Reson Imaging 8: 1073-1078, 1998.
20. Muller RD, Vogel K, Neumann K e Coll: SPIO-MR imaging versus double phase spiral CT in detecting malignant lesions of the liver. Acta Radiol 40: 628-635, 1999.
21. Oudkerk M, G.van den Heuvel A, Wielopolski P e Coll: Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging. Radiology 203: 449-456, 1997.
22. Ros PR, Freeny PC, Harms SE e Coll: Hepatic MR imaging with ferumoxides: a multicentric clinical trial of the safety and efficacity in the detection of focal hepatic lesions. Radiology 196: 481-478, 1995.
23. Rummeny EJ, Marchal G: Liver imaging. Clinical applications and future perspectives. Acta Radiol 38: 626-630, 1997.
24. Rustgi VK: Epidemiology of hepatocellular carcinoma. Gastroenterol Clin North Am 16: 545-549, 1987.
25. Senèterre E, Taourel P, Bouvier Y e Coll: Detection of hepatic metastasis: ferumoxides-enhanced MR Imaging versus unhenanced MR Imaging and CT during arterial portography. Radiology 200: 785-792, 1996.
26. Takayashu K, Moriyama N, Muramatsu Y e Coll: The diagnosis of small hepatocellular carcinomas: efficacity of various imaging procedures in 100 patients. AJR 155: 49-54, 1990.
27. Tang Y, Yamashita Y, Arakawa A e Coll: Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of Gadolinium and Ferumoxides-enhanced MR Imaging. AJR 172: 1547-1554, 1999.
28. Vogl TJ, Hammerstingl R, Schwarz W e Coll: Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR Imaging for differential diagnosis of focal liver lesions. Radiology 198: 881-887, 1996.
29. Vogl TJ, Hammerstingl R, Schwarz e Coll: Magnetic Resonance Imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide Resovist versus gadolinium-DTPA in the same patient. Invest Radiol 31: 696-708, 1996.
30. Yamamoto H, Yamashita Y, Yoshimatsu S e Coll: Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR Imaging. Radiology 195: 106-112, 1995.
31. Yamashita Y, Mitsuzaki K, Yi T e Coll: Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology 200: 79-84, 1996.